silver nitrate has been researched along with Corneal Neovascularization in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozkurt, G; Cakmak, H; Ergin, K; Gokmen, E; Kocaturk, T | 1 |
| Bilgin, S | 1 |
| Azrad-Lebovitz, T; Brookman, M; Friedman, M; Goldenberg-Cohen, N; Hochhauser, E; Marianayagam, NJ; Michowiz, S; Morzaev, D; Nicholson, JD; Zahavi, A | 1 |
| Cho, CH; Choi, JS; Joo, CK; Kim, BH; Kim, TY; Koh, GY; Lee, J; Park, DY; Park, TK; Song, HY; Ye, SK | 1 |
| Elkiran, T; Güler, M; Ozercan, I; Yilmaz, T | 1 |
| Avisar, I; Kremer, I; Weinberger, D | 1 |
| Guan, M; Jin, J; Ma, JX; Yao, K | 1 |
| Aydın, B; Erdurmuş, M; Karadağ, R; Keskin, U; Totan, Y | 1 |
| Carvounis, PE; Chévez-Barrios, P; Khan, P; Kivilcim, M; Lake, JC; Manzano, RP; Peyman, GA; Ren, M | 1 |
| Conway, MD; DellaCroce, JT; Kivilcim, M; Morales, AM; Peyman, GA | 1 |
| Benelli, U; Bernardini, N; Bianchi, F; Danesi, R; Del Tacca, M; Lepri, A; Lupetti, M; Nardi, M | 1 |
| Benelli, U; Danesi, R; Del Tacca, M; Lepri, A; Nardi, M | 1 |
| Benelli, U; Klintworth, GK; Nardi, M; Ross, JR | 1 |
| Celebi, S; Celiker, H; Celiker, UO; Demir, T; Kükner, A; Mogulkoç, R | 1 |
| Courtois, Y; Goureau, O; Sennlaub, F | 1 |
| Brankov, M; Constable, IJ; Kovesdi, I; Lai, CM; Lai, YK; Rakoczy, PE; Shen, WY; Zaknich, T | 1 |
| Feng, K; Li, B; Yang, J | 1 |
17 other study(ies) available for silver nitrate and Corneal Neovascularization
| Article | Year |
|---|---|
Effects of sunitinib and bevacizumab on VEGF and miRNA levels on corneal neovascularization.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Cornea; Corneal Neovascularization; Indoles; Male; MicroRNAs; Pyrroles; Rats; Silver Nitrate; Sunitinib; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2018 |
Comparison of the Effects of Subconjunctival Injections of Bevacizumab and Interferon Alpha-2a on Corneal Angiogenesis in a Rat Model.
Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Conjunctiva; Corneal Neovascularization; Disease Models, Animal; Drug Evaluation, Preclinical; Injections, Intraocular; Interferon alpha-2; Nitrates; Potassium Compounds; Rats; Rats, Wistar; Silver Nitrate; Time Factors | 2018 |
Protective Effect of TLR4 Ablation against Corneal Neovascularization following Chemical Burn in a Mouse Model.
Topics: Animals; Burns, Chemical; Cornea; Corneal Neovascularization; Disease Models, Animal; Drug Combinations; Eye Burns; Fluorescein Angiography; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation; Leukocyte Common Antigens; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitrates; Photography; Potassium Compounds; Real-Time Polymerase Chain Reaction; Silver Nitrate; Toll-Like Receptor 4; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2019 |
Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization.
Topics: Alkaloids; Angiogenesis Inhibitors; Angiopoietin-2; Animals; Benzodioxoles; Corneal Neovascularization; Diabetic Retinopathy; Disease Models, Animal; Down-Regulation; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Lymphangiogenesis; Mice; Neovascularization, Pathologic; NF-kappa B; Oxygen; Primary Cell Culture; Rats; Retina; Silver Nitrate; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
The inhibitory effects of trastuzumab on corneal neovascularization.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Corneal Neovascularization; Corneal Stroma; Disease Models, Animal; Endothelium, Corneal; Epithelium, Corneal; Immunoenzyme Techniques; Injections, Intraperitoneal; Male; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Wistar; Receptor, ErbB-2; Silver Nitrate; Trastuzumab; Vascular Endothelial Growth Factor A | 2009 |
Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Conjunctiva; Corneal Neovascularization; Disease Models, Animal; Drug Administration Routes; Injections; Male; Mice; Mice, Inbred C57BL; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Silver Nitrate; Treatment Outcome; Vascular Endothelial Growth Factor A; Vitreous Body | 2010 |
Inhibition of chemical cautery-induced corneal neovascularization by topical pigment epithelium-derived factor eyedrops.
Topics: Administration, Topical; Animals; Antigens, CD34; Blotting, Western; Cautery; Chloramphenicol; Chondroitin Sulfates; Corneal Neovascularization; Disease Models, Animal; Eye Proteins; Immunohistochemistry; Male; Nerve Growth Factors; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Serpins; Silver Nitrate; Vascular Endothelial Growth Factor A | 2010 |
Inhibitory effects of SU5416, a selective vascular endothelial growth factor receptor tyrosine kinase inhibitor, on experimental corneal neovascularization.
Topics: Angiogenesis Inhibitors; Animals; Cautery; Corneal Neovascularization; Disease Models, Animal; Indoles; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Pyrroles; Silver Nitrate; Vascular Endothelial Growth Factor Receptor-2 | 2012 |
Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin).
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Corneal Neovascularization; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Photography; Rats; Rats, Long-Evans; Silver Nitrate; Vascular Endothelial Growth Factor A | 2007 |
Inhibition of corneal angiogenesis by ascorbic acid in the rat model.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Antioxidants; Ascorbic Acid; Corneal Neovascularization; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Hydrogen-Ion Concentration; Nitrates; Potassium Compounds; Rats; Rats, Long-Evans; Silver Nitrate | 2007 |
Effect of low molecular weight heparan sulphate on angiogenesis in the rat cornea after chemical cauterization.
Topics: Animals; Cornea; Corneal Neovascularization; Drug Therapy, Combination; Female; Fibroblast Growth Factor 2; Heparin; Heparitin Sulfate; Hydrocortisone; Immunoenzyme Techniques; Molecular Weight; Nitrates; Ophthalmic Solutions; Potassium Compounds; Random Allocation; Rats; Rats, Wistar; Silver Nitrate | 1994 |
Trapidil inhibits endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane and in the rat cornea.
Topics: Allantois; Animals; Anti-Inflammatory Agents; Cell Division; Chick Embryo; Chorion; Cornea; Corneal Neovascularization; Drug Therapy, Combination; Endothelium, Vascular; Humans; Hydrocortisone; Male; Neovascularization, Physiologic; Nitrates; Ophthalmic Solutions; Potassium Compounds; Rats; Rats, Wistar; Silver Nitrate; Trapidil; Umbilical Veins; Vasodilator Agents | 1995 |
Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A.
Topics: Administration, Topical; Animals; Cautery; Cornea; Corneal Neovascularization; Corneal Transplantation; Cyclosporine; Drug Combinations; Guinea Pigs; Image Processing, Computer-Assisted; Immunosuppressive Agents; Injections, Subcutaneous; Male; Nitrates; Ophthalmic Solutions; Potassium Compounds; Rats; Rats, Inbred Lew; Silver Nitrate; Transplantation, Heterologous | 1997 |
Effect of Octreotide on experimental corneal neovascularization.
Topics: Animals; Antineoplastic Agents, Hormonal; Cornea; Corneal Neovascularization; Disease Models, Animal; Female; Injections, Subcutaneous; Male; Octreotide; Random Allocation; Rats; Rats, Wistar; Silver Nitrate | 1999 |
Nitric oxide synthase-II is expressed in severe corneal alkali burns and inhibits neovascularization.
Topics: Animals; Burns, Chemical; Cornea; Corneal Neovascularization; DNA Primers; Eye Burns; Female; Gene Expression; Immunoenzyme Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Silver Nitrate | 1999 |
Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization.
Topics: Adenoviridae; Angiogenesis Inhibitors; Animals; beta-Galactosidase; Blotting, Western; Cell Line; Cornea; Corneal Neovascularization; Endothelial Growth Factors; Endothelium, Vascular; Eye; Genetic Vectors; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Lymphokines; Neovascularization, Pathologic; Nitrates; Potassium Compounds; Proto-Oncogene Proteins; Rats; Receptor Protein-Tyrosine Kinases; Silver Nitrate; Time Factors; Transduction, Genetic; Transgenes; Umbilical Veins; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors | 2001 |
[An investigation on morphology of experimental corneal neovascularization].
Topics: Animals; Beta Particles; Cornea; Corneal Neovascularization; Rabbits; Silver Nitrate | 2001 |